Albert Labs International Company Description

Albert Labs International Corp., a biopharmaceutical drug discovery company, researches and develops drugs for psychedelic-assisted therapy for patients with urgent and unmet needs in Canada and the United Kingdom.

It develops KRN-101, is a solution for cancer-related anxiety. The company is based in Burnaby, Canada.

Albert Labs International Corp.

Country	Canada
Industry	Biotechnology
Sector	Healthcare
CEO	Navchand Jagpal

Contact Details

Address: 201-6996 Merritt Avenue Burnaby, V5J 4R6 Canada
Phone	778 819 0740
Website	albertlabs.com

Stock Details

Ticker Symbol	ABRT
Exchange	Canadian Securities Exchange
Fiscal Year	January - December
Reporting Currency	CAD
ISIN Number	CA0127841041
SIC Code	2836

Key Executives

Name	Position
Navchand Jagpal	Acting Chief Executive Officer, Chief Financial Officer and Director
Santoke Naal	Chief Operating Officer
Toby Sorabjee	Chief Communications Officer
Dr. Malcolm Barratt-Johnson	Chief Medical Officer